Global Fragment Based Drug Discovery Market Size
Market Size in USD Bn
CAGR11.8%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 11.8% |
| Market Concentration | High |
| Major Players | Astex Pharmaceuticals, Beactica AB, Charles River Laboratories International, Inc., Evotec AG, Alveus Pharmaceuticals Pvt. Ltd. and Among Others |
please let us know !
Global Fragment Based Drug Discovery Market Analysis
The Global Fragment Based Drug Discovery Market is estimated to be valued at USD 1.35 Bn in 2025 and is expected to reach USD 2.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032. This significant growth can be attributed to increasing adoption of fragment-based methods over high-throughput screening.
The market is expected to witness notable growth over the forecast period. Increased R&D investments from pharmaceutical companies for drug discovery along with rapid adoption of fragment-based screening over other traditional methods are some key factors driving the market. Additionally, availability of advanced technologies for structural determination and characterization of fragments has propelled the market growth over the years.